Sargent Investment Group’s Gilead Sciences GILD Stock Holding History

Sargent Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Buy	11,044 +1,453	+15%	+$203K	0.2%	93
2025 Q4	$1.18M	Sell	9,591 -1,737	-15%	-$211K	0.15%	106
2025 Q3	$1.26M	Buy	11,328 +2,336	+26%	+$266K	0.18%	87
2025 Q2	$992K	Buy	8,992 +2,576	+40%	+$274K	0.13%	101
2025 Q1	$719K	Buy	6,416 +1,362	+27%	+$141K	0.11%	117
2024 Q4	$455K	Buy	+5,054	New	+$455K	0.07%	139
2020 Q4	–	Sell	-4,425	Closed	-$280K	–	192
2020 Q3	$280K	Sell	4,425 -1,109	-20%	-$76.9K	0.1%	134
2020 Q2	$421K	Buy	+5,534	New	+$424K	0.16%	104

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sargent Investment Group's GILD Position: Q1 2026 in Review

Sargent Investment Group increased its Gilead Sciences (GILD) stake by 15% in Q1 2026, buying an estimated $203K and bringing the position to 11,044 shares worth $1.54M. The position accounts for 0.2% of the portfolio, ranked #93.

Sargent Investment Group first reported a position in GILD in Q2 2020 and has held it in 8 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Sargent Investment Group held 11,044 shares of Gilead Sciences worth $1.54M as of Q1 2026.
Sargent Investment Group bought 1,453 Gilead Sciences shares in Q1 2026, an estimated $203K.
Gilead Sciences made up 0.2% of Sargent Investment Group's portfolio in Q1 2026, its #93 holding.
Sargent Investment Group first reported a position in Gilead Sciences in Q2 2020 and has held it in 8 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.